CytoSorbents Corp (CTSO)
0.9676
+0.10
(+11.69%)
USD |
NASDAQ |
May 17, 16:00
0.9606
-0.01
(-0.72%)
After-Hours: 20:00
CytoSorbents Research and Development Expense (TTM): 13.76M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 13.76M |
| December 31, 2023 | 15.73M |
| September 30, 2023 | 15.03M |
| June 30, 2023 | 14.58M |
| March 31, 2023 | 15.09M |
| December 31, 2022 | 15.12M |
| September 30, 2022 | 17.85M |
| June 30, 2022 | 18.83M |
| March 31, 2022 | 18.34M |
| December 31, 2021 | 16.38M |
| September 30, 2021 | 12.93M |
| June 30, 2021 | 10.42M |
| March 31, 2021 | 9.127M |
| December 31, 2020 | 8.811M |
| September 30, 2020 | 9.683M |
| June 30, 2020 | 11.11M |
| March 31, 2020 | 11.64M |
| December 31, 2019 | 12.09M |
| September 30, 2019 | 10.96M |
| June 30, 2019 | 9.715M |
| March 31, 2019 | 8.361M |
| December 31, 2018 | 7.668M |
| September 30, 2018 | 6.910M |
| June 30, 2018 | 5.61M |
| March 31, 2018 | 4.492M |
| Date | Value |
|---|---|
| December 31, 2017 | 3.236M |
| September 30, 2017 | 2.524M |
| June 30, 2017 | 3.052M |
| March 31, 2017 | 3.686M |
| December 31, 2016 | 4.073M |
| September 30, 2016 | 4.372M |
| June 30, 2016 | 4.067M |
| March 31, 2016 | 3.776M |
| December 31, 2015 | 3.871M |
| September 30, 2015 | 3.587M |
| June 30, 2015 | 3.601M |
| March 31, 2015 | 3.146M |
| December 31, 2014 | 2.432M |
| September 30, 2014 | 1.496M |
| June 30, 2014 | 0.9104M |
| March 31, 2014 | 1.272M |
| December 31, 2013 | 1.739M |
| September 30, 2013 | 2.385M |
| June 30, 2013 | 2.645M |
| March 31, 2013 | 2.652M |
| December 31, 2012 | 2.581M |
| September 30, 2012 | 2.398M |
| June 30, 2012 | 2.623M |
| March 31, 2012 | 2.762M |
| December 31, 2011 | 2.888M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
8.811M
Minimum
Dec 2020
18.83M
Maximum
Jun 2022
13.36M
Average
13.35M
Median
Research and Development Expense (TTM) Benchmarks
| Delcath Systems Inc | 16.63M |
| Star Equity Holdings Inc | -- |
| Exact Sciences Corp | 441.07M |
| Illumina Inc | 1.353B |
| Progyny Inc | -- |